NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,749,909 | +6.8% | 17,180 | +5.8% | 0.15% | +13.5% |
| Q2 2023 | $1,638,431 | +5.4% | 16,241 | -3.8% | 0.13% | -7.0% |
| Q1 2023 | $1,553,839 | -49.8% | 16,890 | -50.5% | 0.14% | -46.6% |
| Q4 2022 | $3,097,181 | -12.1% | 34,140 | -26.3% | 0.27% | -23.4% |
| Q3 2022 | $3,523,000 | -15.1% | 46,348 | -5.6% | 0.35% | -16.1% |
| Q2 2022 | $4,150,000 | -9.0% | 49,099 | -5.5% | 0.42% | +4.2% |
| Q1 2022 | $4,560,000 | -9.6% | 51,969 | -9.9% | 0.40% | +7.2% |
| Q4 2021 | $5,045,000 | +4.8% | 57,672 | -2.0% | 0.37% | -6.0% |
| Q3 2021 | $4,814,000 | -9.3% | 58,871 | +1.2% | 0.40% | -9.2% |
| Q2 2021 | $5,309,000 | +4.1% | 58,182 | -2.5% | 0.44% | -7.0% |
| Q1 2021 | $5,098,000 | +128.5% | 59,645 | +144.1% | 0.47% | +56.1% |
| Q2 2019 | $2,231,000 | -52.9% | 24,437 | -50.4% | 0.30% | -9.9% |
| Q1 2019 | $4,734,000 | +98.2% | 49,232 | +76.9% | 0.33% | +92.0% |
| Q4 2018 | $2,388,000 | – | 27,832 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |